Decision: Favourable

Decisions Table

Study Title:

A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis with rVWF in Children Diagnosed With Severe von Willebrand disease

  • NREC Code:

    23-NREC-CT-027

  • Decision:

    Favourable

  • Meeting Date:

    05/04/2023

  • Study Type:

    CT application

  • Principal Investigator:

    Dr Elizabeth Mary Beatrice Nolan

  • PI Institution:

    CHI Crumlin

  • Sponsor:

    Takeda Development Center Americas, Inc.

Scroll to Top